Cargando…
COVID-19 and COPD
COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways. https://bit.ly/37dSB8l
Autores principales: | Leung, Janice M., Niikura, Masahiro, Yang, Cheng Wei Tony, Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424116/ https://www.ncbi.nlm.nih.gov/pubmed/32817205 http://dx.doi.org/10.1183/13993003.02108-2020 |
Ejemplares similares
-
A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation
por: Chen, Yu-Wei Roy, et al.
Publicado: (2016) -
COVID-19 in COPD: A growing concern
por: Sin, Don D.
Publicado: (2020) -
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020) -
Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020) -
Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)